Veeva Systems (VEEV)
(Delayed Data from NYSE)
$204.67 USD
+0.14 (0.07%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $204.53 -0.14 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$204.67 USD
+0.14 (0.07%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $204.53 -0.14 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Zacks News
Thermo Fisher (TMO) Rides on APAC Strength Despite Cost Woes
by Zacks Equity Research
Thermo Fisher (TMO) is registering a sturdy global footprint with strong growth seen in Asia-Pacific including China.
Has Veeva Systems (VEEV) Outpaced Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (VEEV) Outperforming Other Computer and Technology Stocks This Year?
Express Scripts & Petco Tie Up, Ease Access to Pet Medicines
by Zacks Equity Research
Express Scripts' (ESRX) Inside Rx Pets discount card is likely to make pet medicines affordable.
Boston Scientific's (BSX) $4.2B Buyout to Augment PI Business
by Zacks Equity Research
Boston Scientific (BSX) continues to expand on the back of its inorganic growth strategy. The latest takeover is expected to boost the PI business.
Veeva Systems (VEEV) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed the most recent trading day at $85.52, moving +0.9% from the previous trading session.
Medtronic Moves a Step Ahead With Mazor Robotics Buyout
by Zacks Equity Research
Medtronic's (MDT) resolve to take over the Israel-based robotic surgical guidance systems company, Mazor Robotics, adheres to its goal to grow in the sphere of robotics spine surgery.
Edwards Lifesciences' CE Mark for SAPIEN 3 Boosts THVT Arm
by Zacks Equity Research
Latest CE Mark receipt is expected to fortify Edwards Lifesciences' (EW) position in Europe.
Hill-Rom Rides on New Products, Asia Pacific Sales Drop
by Zacks Equity Research
Hill Rom (HRC) sets sights on product innovation. In patient support systems, the company unveils Hill-Rom Envella Air Fluidized Therapy Bed.
GNC Holdings Domestic Revenues Soft, Global Growth Strong
by Zacks Equity Research
Within same store, GNC Holdings (GNC) disappoints on the domestic franchise locations front. However, its steadily thriving international business is a big boon.
Will Strong RTG Arm Shape Medtronic's (MDT) Q2 Earnings?
by Zacks Equity Research
Medtronic (MDT) poised to gain on continued RTG business growth in Q2.
Merit Medical (MMSI) Completes Cianna Medical Acquisition
by Zacks Equity Research
Merit Medical (MMSI) is likely to gain traction in the global breast lesion localization market, courtesy of the Cianna Medical acquisition.
Medidata's Cloud Platform Picked by China's Hengrui, Stock Up
by Zacks Equity Research
Medidata's (MDSO) cloud-based platform sees immense prospects in APAC.
Baxter (BAX) Launches Peri-Strips & Tisseel Prima, Shares Up
by Zacks Equity Research
Baxter's (BAX) diversified surgical portfolio lends it a competitive edge in the MedTech space.
Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now
by Zacks Equity Research
Solid fiscal Q4 for Becton, Dickinson (BDX); headwinds apprehended in fiscal 2019.
ResMed (RMD) Closes MatrixCare Buyout, Boosts SaaS Line
by Zacks Equity Research
Post culmination of the transaction, MatrixCare will continue to operate as a standalone business within ResMed's (RMD) SaaS portfolio.
Haemonetics Strong on Plasma & Hemostasis Management Units
by Zacks Equity Research
Haemonetics (HAE) sees encouraging growth at the North America Plasma revenues on strong disposables along with growing software revenues.
NuVasive Porous PEEK Implant OK'd for Use in XLIF Procedure
by Zacks Equity Research
NuVasive (NUVA) adopts initiatives to boost the U.S. Spinal Hardware unit.
Twitter, Marriott Vacations, Veeva, Attunity and Apptio highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Twitter, Marriott Vacations, Veeva, Attunity and Apptio highlighted as Zacks Bull and Bear of the Day
3 Cloud Stocks to Buy Right Now
by Ryan McQueeney
In a matter of just a few years, "the Cloud" has evolved from a budding new tech feature to one of the main factors driving growth in the technology sector. We've highlighted three stocks that are showing strong cloud-related activity and strong fundamental metrics. Check out these three cloud stocks to buy right now!
Veeva Systems (VEEV) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed at $89.65 in the latest trading session, marking a -0.96% move from the prior day.
Bio-Rad Clinches USDA Contract, Boosts Life Science Segment
by Zacks Equity Research
Bio-Rad (BIO) adopts initiatives to boost Life Science unit.
BD's FDA Nod for Phoenix Test Boosts Diagnostic Systems
by Zacks Equity Research
BD's (BDX) diagnostics portfolio boasts tests used for rapid susceptibility testing.
Veeva Systems (VEEV) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed at $96.63 in the latest trading session, marking a -0.54% move from the prior day.
Is Veeva Systems (VEEV) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (VEEV) Outperforming Other Computer and Technology Stocks This Year?
Veeva Systems (VEEV) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Veeva Systems (VEEV) closed at $92.45, marking a +1.2% move from the previous day.